Integrated Hemostasis Bypass Valve Patent Application

ChangeBridge: EPO Bulletin - Medical Devices (A61M)

Published March 25th, 2026

Detected April 1st, 2026

Summary

The European Patent Office published patent application EP4233980A1 for St. Jude Medical's integrated hemostasis bypass valve. The invention covers a medical device designed to control blood flow during medical procedures. The application designates most EU member states plus Switzerland, Norway, Turkey, and other European countries.

View original document View source feed page

What changed

St. Jude Medical, Cardiology Division, Inc. filed European patent application EP4233980A1 for an integrated hemostasis bypass valve. The IPC classifications indicate the device relates to A61M 39/00 and A61M 39/06 (tubular body duct access devices), A61M 25/00 and A61M 25/01 (catheters and catheter insertion techniques). Inventors include Eidenschink, Glimsdale, Perszyk, and Osterbauer.

Patent publications are informational filings and create no immediate compliance obligations. Competitors developing similar hemostasis control or catheter-based access devices should review the claims to assess potential freedom-to-operate implications. No deadlines or penalties are associated with this publication.

Source document (simplified)

← EPO Patent Bulletin

INTEGRATED HEMOSTASIS BYPASS VALVE

Publication EP4233980A1 Kind: A1 Mar 25, 2026

Applicants

St. Jude Medical, Cardiology Division, Inc.

Inventors

Eidenschink, Tracee, Glimsdale, Mathias C., Perszyk, Brian Joseph, Osterbauer, Philip

IPC Classifications

A61M 39/00 20060101AFI20250926BHEP A61M 39/06 20060101ALI20250926BHEP A61M 25/00 20060101ALI20250926BHEP A61M 25/01 20060101ALI20250926BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →